Naska Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NASKA, and what generic and branded alternatives to NASKA drugs are available?
NASKA has ten approved drugs.
Drugs and US Patents for Naska
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Naska | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | SYRUP;ORAL | 089021-001 | Dec 21, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Naska | TRIMETH/SULFA | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 072399-001 | May 23, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Naska | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062674-001 | Mar 10, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.